Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis

Optimal treatment regimen for patients with antiphospholipid syndrome (APS) remain unclear. Therefore, the authors sought to compare the outcomes of vitamin K antagonists (VKAs) vs. direct oral anticoagulants (DOACs) in patients with APS. METHODS: MEDLINE, Embase, and Cochrane Central databases were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Bidhan Bikram, Shankar, Abhirami, Kumar, Vinesh, Kumar, Sumeet, Malik, Umair Arshad, Majeed, Abdul, Kumar, Vijay, Berkha, Suman, Netha, Aadarsh, Subedi, Sonika, Ahmed, Shoaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328675/
https://www.ncbi.nlm.nih.gov/pubmed/37427194
http://dx.doi.org/10.1097/MS9.0000000000000903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328675/
https://www.ncbi.nlm.nih.gov/pubmed/37427194
http://dx.doi.org/10.1097/MS9.0000000000000903

Ejemplares similares